Search Results - "E. Kerzberg"

Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial by Eastell, R, Lang, T, Boonen, S, Cummings, S, Delmas, P. D, Cauley, J. A, Horowitz, Z, Kerzberg, E, Bianchi, G, Kendler, D, Leung, P, Man, Z, Mesenbrink, P, Eriksen, E. F, Black, D. M

“…Summary Changes in bone mineral density and bone strength following treatment with zoledronic acid (ZOL) were measured by quantitative computed analysis (QCT)…”
Get full text

Rendimiento del ASAS Health Index en pacientes con Espondiloartritis de la vida real by M. V. Martire, P. Girard Bosch, C. Airoldi, M. Benegas, V. Cosentino, V. Duarte, J. Marin, J. M. Bande, M. J. Gamba, F. Sommerfleck, P. González, D. Vila, M. Oliver, L. García, E. J. Velozo, E. Kerzberg, J. Tapia, M. Cosatti, P. Giorgis, R. Nieto, S. Scarafia, E. E. Schneeberger

“…Introducción: el cuestionario “Assessment of Spondyloarthritis International Society Health In- dex” (ASAS-HI) fue desarrollado para medir de manera global la…”
Get full text

Sexto reporte de eventos adversos con tratamientos biológicos en Argentina. Informe del registro BIOBADASAR by G. Gómez, G. Pons-Estel, G. Citera, E. Soriano, V. Saurit, F. Benavidez, E. Velozo, D. Dubinsky, I. Exeni, C. Gobi, G. Gómez, M. Díaz, A. Granel, A. Smichowsky, G. Garate, A. Quinteros, E. Cavillon, I. Petkovic, M.S. Larroude, M. de la Sota, A.M. Cappuccio, G. Berbotto, A. Alvarez, S. Papasidero, A. Lazaro, M. Garcia, M. Sacnun, S. Soares de Souza, A. Bertoli, V. Bejarano, O. Rillo, E. Kerzberg, R. Quintana, S. Agüero, L. Somma, V. Cruzat, C. Battaglitti, A. Perez Dávila, M. Gallardo, D. Pereira, M. Verando, S. Paira, L. Martinez, N. Aste, C. Pisoni, E. Catay, C. Graf, G. Casado, M. de la Vega

“…Objetivo: actualizar los resultados del registro BIOBADASAR sobre seguridad, duración y causas de interrupción del tratamiento luego de 8 años de seguimiento…”
Get full text

Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort by Hughes, Michael, Huang, Suiyuan, Alegre-Sancho, Juan Jose, Carreira, Patricia E, Engelhart, Merete, Hachulla, Eric, Henes, Joerg, Kerzberg, Eduardo, Pozzi, Maria Rosa, Riemekasten, Gabriela, Smith, Vanessa, Szücs, Gabriella, Vanthuyne, Marie, Zanatta, Elisabetta, Distler, Oliver, Gabrielli, Armando G, Hoffmann-Vold, Anna-Maria, Steen, Virginia D, Khanna, Dinesh

“…The early trajectory of skin fibrosis provides insights into the disease course of systemic sclerosis (SSc) including mortality; however, little is known about…”
Get full text

Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study by Pappas, Dimitrios A., Nyberg, Fredrik, Kremer, Joel M., Lampl, Kathy, Reed, George W., Horne, Laura, Ho, Meilien, Onofrei, Alina, Malaviya, Anand N., Rillo, Oscar L., Radominski, Sebastiao C., Gal, Janos, Gibofsky, Allan, Popkova, Tatiana V., Laurindo, Leda, Kerzberg, Eduardo M., Zahora, Roman, Pons-Estel, Bernado A., Curtis, Jeffrey R., Furst, Daniel E., Greenberg, Jeffrey D.

“…To compare the prevalence of cardiovascular disease (CVD) and major CVD risk factors among rheumatoid arthritis (RA) patients enrolled in a large US and…”
Get full text

Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent? by Khan, Nasim Ahmed, Spencer, Horace Jack, Abda, Essam Ahmed, Alten, Rieke, Pohl, Christof, Ancuta, Codrina, Cazzato, Massimiliano, Géher, Pál, Gossec, Laure, Henrohn, Dan, Hetland, Merete Lund, Inanc, Nevsun, Jacobs, Johannes Wg, Kerzberg, Eduardo, Majdan, Maria, Oyoo, Omondi, Peredo-Wende, Ruben A, Selim, Zahraa Ibrahim, Skopouli, Fotini Nikolaos, Sulli, Alberto, Hørslev-Petersen, Kim, Taylor, Peter C, Sokka, Tuulikki

“…To assess (A) determinants of patient's global assessment of disease activity (PTGL) and patient's assessment of general health (GH) scores of rheumatoid…”
Get more information

The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program by Grøn, Kathrine Lederballe, Ornbjerg, Lykke Midtbøll, Hetland, Merete Lund, Aslam, Fawad, Khan, Nasim A, Jacobs, Johannes W G, Henrohn, Dan, Rasker, J J, Kauppi, Markku J, Lang, Hui-Chu, Mota, Licia M H, Aggarwal, Amita, Yamanaka, Hisahi, Badsha, Humeira, Gossec, Laure, Cutolo, Maurizio, Ferraccioli, Gianfranco, Gremese, Elisa, Bong Lee, Eun, Inanc, Nevsun, Direskeneli, Haner, Taylor, Peter, Huisman, Margriet, Alten, Rieke, Pohl, Christoph, Oyoo, Omondi, Stropuviene, Sigita, Drosos, Alexandrosos A, Kerzberg, Eduardo, Ancuta, Codorina, Mofti, Ayman, Bergman, Martin, Detert, Jaqueline, Selim, Zaraa I, Abda, Essam A, Rexhepi, Blerta, Sokka, Tuulikki

“…The aim is to assess the prevalence of comorbidities and to further analyse to which degree fatigue can be explained by comorbidity burden, disease activity,…”
Get full text

ASAS Health Index performance in real-life Spondyloarthritis patients by Martire, M. V., Girard Bosch, P., Airoldi, C., Benegas, M., Cosentino, V., Marin, J., Duarte, V., Bande, J. M., Gamba, M. J., Sommerfleck, F., Gonzalez, P., Vila, D., Oliver, M., García, L., Velozo, E. J., Kerzberg, E., Tapia, J., Cosatti, M., Giorgis, P., Nieto, R., Scarafia, S., Schneeberger, E. E.

“…Introduction: the “Assessment of Spondyloarthritis International Society Health Index” (ASASHI) questionnaire was developed to globally measure function and…”
Get full text

Serum kinetics, bioavailability and bone scanning of 99mTc-labelled sodium olpadronate in patients with different rates of bone turnover by DEGROSSI, O. J, ORTIZ, M, DEGROSSI, E. B, GARCIA DEL RIO, H, BARREIRA, J. C, MESSINA, D, KERZBERG, E, ROLDAN, E. J. A, MONTUORI, E, PEREZ LLOREST, A

“…The activity of olpadronate labelled with technetium-99m(99mTc) was monitored in plasma and urine samples after single oral (925 MBq 99mTc/10 mg,…”
Get full text

Combination of glycosaminoglycans and acetylsalicylic acid in knee osteoarthrosis by Kerzberg, E M, Roldán, E J, Castelli, G, Huberman, E D

Get more information

Sixth report of adverse events with biological treatments in Argentina. BIOBADASAR registry report by Gómez, G., Pons-Estel, G., Citera, G., Soriano, E., Saurit, V., Benavidez, F., Velozo, E., Dubinsky, D., Exeni, I., Gobi, C., Díaz, M., Granel, A., Smichowsky, A., Garate, G., Quinteros, A., Cavillon, E., Petkovic, I., Larroude, M.S., de la Sota, M., Cappuccio, A.M., Berbotto, G., Alvarez, A., Papasidero, S., Lazaro, A., Garcia, M., Sacnun, M., Soares de Souza, S., Bertoli, A., Bejarano, V., Rillo, O., Kerzberg, E., Quintana, R., Agüero, S., Somma, L., Cruzat, V., Battaglitti, C., Perez Dávila, A., Gallardo, M., Pereira, D., Verando, M., Paira, S., Martinez, L., Aste, N., Pisoni, C., Catay, E., Graf, C., Casado, G., de la Vega, M.

“…Objective: update the results of the BIOBADASAR registry on safety, duration and causes of treatment interruption after 8 years of follow-up. Methods:…”
Get full text

The Effects of Tibolone in Older Postmenopausal Women by Cummings, Steven R, Ettinger, Bruce, Delmas, Pierre D, Kenemans, Peter, Stathopoulos, Victoria, Verweij, Pierre, Mol-Arts, Mirjam, Kloosterboer, Lenus, Mosca, Lori, Christiansen, Claus, Bilezikian, John, Kerzberg, Eduardo Mario, Johnson, Susan, Zanchetta, Jose, Grobbee, Diederich E, Seifert, Wilfried, Eastell, Richard

“…In this trial, tibolone, which has estrogenic, progestogenic, and androgenic effects, was compared with placebo in women between 60 and 85 who had osteoporosis…”
Get full text

Effect of low doses of oral pamidronate (APD) on the calcemia of osteopenic or osteoporotic patients by Roldan, E J, Kerzberg, E M, Castelli, G, Lloret, A P

“…Oral pamidronate (APD) at high doses (400-900 mg/day) is employed as antiresorptive agent for the treatment of Paget's disease. In some occasions hypocalcemia…”
Get more information

Hand bone densitometry in rheumatoid arthritis by Marcos, V, Cavallo, A, Sequeira, G, Roldán, E, Kerzberg, E

Get full text

Una encuesta sobre la evaluación y el tratamiento actual de la gota en Buenos Aires, Argentina by Fara, Nauan, Vázquez Mellado, Janitzia, Sequeira, Gabriel, Kerzberg, Eduardo

“…Resumen Objetivo Evaluar la gestión actual de la gota en los médicos generales y especialistas en Buenos Aires. Material y métodos Preguntas de selección…”
Get full text

Kinetics of chemoluminiscence of rat intestine during ischemia and reperfusion by Roldán, E J, Kerzberg, E M, Boveris, A

“…Oxygen free radicals are involved in ischemic and reperfusion tissular injuries. Chemiluminescence of organs reflects the steady state level of peroxy…”
Get more information

Gastrointestinal involvement in progressive systemic sclerosis by Alvarez, M G, Rubaldo, R E, Kerzberg, E M, De Paula, A, Huberman, E D

“…25 patients with clinical, radiological and manometrical features of PSS in the gastrointestinal tract were reviewed, looking mainly for the esophageal…”
Get more information

Giant duodenal diverticula with heterotopic gastric mucosa. Its demonstration with technetium 99 by Kerzberg, E, Orfus, S, Saleme, J, Slater, H, De Paula, A, Huberman, E

“…The duodenal diverticulum, except for occasional findings, are diagnosed by their complications, these are found in 10% of the cases and they are: 1)…”
Get more information

Colonic angiodysplasia: report of a case and considerations by Kerzberg, E, Rapoport, B, Roldán, M, Sánchez, D, Arzeno, J, Huberman, E

“…An important etiology of gastrointestinal disease hemorrhage is the angiodisplasic in the last decades the recognition of this pathology has advanced due to…”
Get more information

Oxidative cellular damage in the digestive system by Roldán, E J, Kerzberg, E M, Huberman, E D

Get more information